TERT-BUTYL 4,4-DIMETHYL-2,2-DIOXOOXATHIAZOLIDINE-3-CARBOXYLATE, 95.0%, 1g

2-BROMO-6-(DIFLUOROMETHOXY)BENZALDEHYDE, 95.0%, 100mg

1-[(1,1-Dimethylethoxy)carbonyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-histidine, 95%, 100g

Quinoxaline-2-carboxylic acid, 98.0%, 10g

Ponceau solution 0.1% in 5% acetic acid, 25g

2-(propan-2-yl)-3,4-dihydropyrimidin-4-one, 95%, 1g

(S)-tert-Butyl 2-(methylamino)propanoate hydrochloride, 95.0%, 1g

2-(4,5-Dimethoxy-2-(((4-(trifluoromethyl)phenyl)amino)sulfonyl)phenyl)acetic acid, 95%, 10g

4-chloro-5-fluoro-1H-indole-2,3-dione, 95.0%, 5g

Benzene-1,3-dithiocarboxamide, 1g

2-(4,4-DIMETHYL-4,5-DIHYDRO-2-OXAZOLYL)PYRIDINE, 95%, 1g

4-Bromo-3-fluorobenzaldehyde, 97.0%, 500g

Colonne capillaire GC ROTI®Cap-5, 50 m, 0,32 mm, 0,50 µm, 1 pièce(s)